N-[4-(6-chloro-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-[6-(cyclohexylcarbamoylamino)-1H-benzimidazol-2-yl]phenyl]cyclohexanecarboxamide;N-[4-(5,6-dichloro-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-(5,6-dimethyl-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-(6-fluoro-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]phenyl]cyclohexanecarboxamide

C130H137Cl3F4N20O7 — CID 161092745

IUPACN-[4-(6-chloro-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-[6-(cyclohexylcarbamoylamino)-1H-benzimidazol-2-yl]phenyl]cyclohexanecarboxamide;N-[4-(5,6-dichloro-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-(5,6-dimethyl-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-(6-fluoro-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]phenyl]cyclohexanecarboxamide
SMILESCc1cc2nc(-c3ccc(NC(=O)C4CCCCC4)cc3)[nH]c2cc1C.O=C(Nc1ccc(-c2nc3cc(Cl)c(Cl)cc3[nH]2)cc1)C1CCCCC1.O=C(Nc1ccc(-c2nc3ccc(C(F)(F)F)cc3[nH]2)cc1)C1CCCCC1.O=C(Nc1ccc(-c2nc3ccc(Cl)cc3[nH]2)cc1)C1CCCCC1.O=C(Nc1ccc(-c2nc3ccc(F)cc3[nH]2)cc1)C1CCCCC1.O=C(Nc1ccc2nc(-c3ccc(NC(=O)C4CCCCC4)cc3)[nH]c2c1)NC1CCCCC1
InChIInChI=1S/C27H33N5O2.C22H25N3O.C21H20F3N3O.C20H19Cl2N3O.C20H20ClN3O.C20H20FN3O/c33-26(19-7-3-1-4-8-19)28-21-13-11-18(12-14-21)25-31-23-16-15-22(17-24(23)32-25)30-27(34)29-20-9-5-2-6-10-20;1-14-12-19-20(13-15(14)2)25-21(24-19)16-8-10-18(11-9-16)23-22(26)17-6-4-3-5-7-17;22-21(23,24)15-8-11-17-18(12-15)27-19(26-17)13-6-9-16(10-7-13)25-20(28)14-4-2-1-3-5-14;21-15-10-17-18(11-16(15)22)25-19(24-17)12-6-8-14(9-7-12)23-20(26)13-4-2-1-3-5-13;2*21-15-8-11-17-18(12-15)24-19(23-17)13-6-9-16(10-7-13)22-20(25)14-4-2-1-3-5-14/h11-17,19-20H,1-10H2,(H,28,33)(H,31,32)(H2,29,30,34);8-13,17H,3-7H2,1-2H3,(H,23,26)(H,24,25);6-12,14H,1-5H2,(H,25,28)(H,26,27);6-11,13H,1-5H2,(H,23,26)(H,24,25);2*6-12,14H,1-5H2,(H,22,25)(H,23,24)
InChIKeyUHJXTSIMGZMOOO-UHFFFAOYSA-N
MW2274.01 g/mol
LogP33.68
Rot. Bonds20

About N-[4-(6-chloro-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-[6-(cyclohexylcarbamoylamino)-1H-benzimidazol-2-yl]phenyl]cyclohexanecarboxamide;N-[4-(5,6-dichloro-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-(5,6-dimethyl-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-(6-fluoro-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]phenyl]cyclohexanecarboxamide

N-[4-(6-chloro-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-[6-(cyclohexylcarbamoylamino)-1H-benzimidazol-2-yl]phenyl]cyclohexanecarboxamide;N-[4-(5,6-dichloro-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-(5,6-dimethyl-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-(6-fluoro-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]phenyl]cyclohexanecarboxamide (PubChem CID 161092745) has the molecular formula C130H137Cl3F4N20O7 and a molecular weight of 2274.01 g/mol. Its IUPAC name is N-[4-(6-chloro-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-[6-(cyclohexylcarbamoylamino)-1H-benzimidazol-2-yl]phenyl]cyclohexanecarboxamide;N-[4-(5,6-dichloro-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-(5,6-dimethyl-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-(6-fluoro-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]phenyl]cyclohexanecarboxamide.

Molecular Properties

Compound NameN-[4-(6-chloro-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-[6-(cyclohexylcarbamoylamino)-1H-benzimidazol-2-yl]phenyl]cyclohexanecarboxamide;N-[4-(5,6-dichloro-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-(5,6-dimethyl-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-(6-fluoro-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]phenyl]cyclohexanecarboxamide
PubChem CID161092745
Molecular FormulaC130H137Cl3F4N20O7
Molecular Weight2274.01 g/mol
Exact Mass2271.00
IUPAC NameN-[4-(6-chloro-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-[6-(cyclohexylcarbamoylamino)-1H-benzimidazol-2-yl]phenyl]cyclohexanecarboxamide;N-[4-(5,6-dichloro-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-(5,6-dimethyl-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-(6-fluoro-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]phenyl]cyclohexanecarboxamide
SMILESCc1cc2nc(-c3ccc(NC(=O)C4CCCCC4)cc3)[nH]c2cc1C.O=C(Nc1ccc(-c2nc3cc(Cl)c(Cl)cc3[nH]2)cc1)C1CCCCC1.O=C(Nc1ccc(-c2nc3ccc(C(F)(F)F)cc3[nH]2)cc1)C1CCCCC1.O=C(Nc1ccc(-c2nc3ccc(Cl)cc3[nH]2)cc1)C1CCCCC1.O=C(Nc1ccc(-c2nc3ccc(F)cc3[nH]2)cc1)C1CCCCC1.O=C(Nc1ccc2nc(-c3ccc(NC(=O)C4CCCCC4)cc3)[nH]c2c1)NC1CCCCC1
InChIInChI=1S/C27H33N5O2.C22H25N3O.C21H20F3N3O.C20H19Cl2N3O.C20H20ClN3O.C20H20FN3O/c33-26(19-7-3-1-4-8-19)28-21-13-11-18(12-14-21)25-31-23-16-15-22(17-24(23)32-25)30-27(34)29-20-9-5-2-6-10-20;1-14-12-19-20(13-15(14)2)25-21(24-19)16-8-10-18(11-9-16)23-22(26)17-6-4-3-5-7-17;22-21(23,24)15-8-11-17-18(12-15)27-19(26-17)13-6-9-16(10-7-13)25-20(28)14-4-2-1-3-5-14;21-15-10-17-18(11-16(15)22)25-19(24-17)12-6-8-14(9-7-12)23-20(26)13-4-2-1-3-5-13;2*21-15-8-11-17-18(12-15)24-19(23-17)13-6-9-16(10-7-13)22-20(25)14-4-2-1-3-5-14/h11-17,19-20H,1-10H2,(H,28,33)(H,31,32)(H2,29,30,34);8-13,17H,3-7H2,1-2H3,(H,23,26)(H,24,25);6-12,14H,1-5H2,(H,25,28)(H,26,27);6-11,13H,1-5H2,(H,23,26)(H,24,25);2*6-12,14H,1-5H2,(H,22,25)(H,23,24)
InChIKeyUHJXTSIMGZMOOO-UHFFFAOYSA-N
XLogP33.68
TPSA387.81 Ų
H-Bond Donors14
H-Bond Acceptors13
Rotatable Bonds20
Heavy Atoms164
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002274.01
LogP ≤ 533.68
H-Bond Donors ≤ 514
H-Bond Acceptors ≤ 1013

Analyze N-[4-(6-chloro-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-[6-(cyclohexylcarbamoylamino)-1H-benzimidazol-2-yl]phenyl]cyclohexanecarboxamide;N-[4-(5,6-dichloro-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-(5,6-dimethyl-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-(6-fluoro-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]phenyl]cyclohexanecarboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[4-(6-chloro-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-[6-(cyclohexylcarbamoylamino)-1H-benzimidazol-2-yl]phenyl]cyclohexanecarboxamide;N-[4-(5,6-dichloro-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-(5,6-dimethyl-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-(6-fluoro-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]phenyl]cyclohexanecarboxamide?
The IUPAC name of N-[4-(6-chloro-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-[6-(cyclohexylcarbamoylamino)-1H-benzimidazol-2-yl]phenyl]cyclohexanecarboxamide;N-[4-(5,6-dichloro-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-(5,6-dimethyl-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-(6-fluoro-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]phenyl]cyclohexanecarboxamide (CID 161092745) is N-[4-(6-chloro-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-[6-(cyclohexylcarbamoylamino)-1H-benzimidazol-2-yl]phenyl]cyclohexanecarboxamide;N-[4-(5,6-dichloro-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-(5,6-dimethyl-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-(6-fluoro-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]phenyl]cyclohexanecarboxamide.
What is the SMILES notation for N-[4-(6-chloro-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-[6-(cyclohexylcarbamoylamino)-1H-benzimidazol-2-yl]phenyl]cyclohexanecarboxamide;N-[4-(5,6-dichloro-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-(5,6-dimethyl-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-(6-fluoro-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]phenyl]cyclohexanecarboxamide?
The canonical SMILES for N-[4-(6-chloro-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-[6-(cyclohexylcarbamoylamino)-1H-benzimidazol-2-yl]phenyl]cyclohexanecarboxamide;N-[4-(5,6-dichloro-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-(5,6-dimethyl-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-(6-fluoro-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]phenyl]cyclohexanecarboxamide is Cc1cc2nc(-c3ccc(NC(=O)C4CCCCC4)cc3)[nH]c2cc1C.O=C(Nc1ccc(-c2nc3cc(Cl)c(Cl)cc3[nH]2)cc1)C1CCCCC1.O=C(Nc1ccc(-c2nc3ccc(C(F)(F)F)cc3[nH]2)cc1)C1CCCCC1.O=C(Nc1ccc(-c2nc3ccc(Cl)cc3[nH]2)cc1)C1CCCCC1.O=C(Nc1ccc(-c2nc3ccc(F)cc3[nH]2)cc1)C1CCCCC1.O=C(Nc1ccc2nc(-c3ccc(NC(=O)C4CCCCC4)cc3)[nH]c2c1)NC1CCCCC1.
What is the InChIKey of N-[4-(6-chloro-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-[6-(cyclohexylcarbamoylamino)-1H-benzimidazol-2-yl]phenyl]cyclohexanecarboxamide;N-[4-(5,6-dichloro-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-(5,6-dimethyl-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-(6-fluoro-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]phenyl]cyclohexanecarboxamide?
The InChIKey is UHJXTSIMGZMOOO-UHFFFAOYSA-N. The full InChI is InChI=1S/C27H33N5O2.C22H25N3O.C21H20F3N3O.C20H19Cl2N3O.C20H20ClN3O.C20H20FN3O/c33-26(19-7-3-1-4-8-19)28-21-13-11-18(12-14-21)25-31-23-16-15-22(17-24(23)32-25)30-27(34)29-20-9-5-2-6-10-20;1-14-12-19-20(13-15(14)2)25-21(24-19)16-8-10-18(11-9-16)23-22(26)17-6-4-3-5-7-17;22-21(23,24)15-8-11-17-18(12-15)27-19(26-17)13-6-9-16(10-7-13)25-20(28)14-4-2-1-3-5-14;21-15-10-17-18(11-16(15)22)25-19(24-17)12-6-8-14(9-7-12)23-20(26)13-4-2-1-3-5-13;2*21-15-8-11-17-18(12-15)24-19(23-17)13-6-9-16(10-7-13)22-20(25)14-4-2-1-3-5-14/h11-17,19-20H,1-10H2,(H,28,33)(H,31,32)(H2,29,30,34);8-13,17H,3-7H2,1-2H3,(H,23,26)(H,24,25);6-12,14H,1-5H2,(H,25,28)(H,26,27);6-11,13H,1-5H2,(H,23,26)(H,24,25);2*6-12,14H,1-5H2,(H,22,25)(H,23,24).
What are the key properties of N-[4-(6-chloro-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-[6-(cyclohexylcarbamoylamino)-1H-benzimidazol-2-yl]phenyl]cyclohexanecarboxamide;N-[4-(5,6-dichloro-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-(5,6-dimethyl-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-(6-fluoro-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]phenyl]cyclohexanecarboxamide?
N-[4-(6-chloro-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-[6-(cyclohexylcarbamoylamino)-1H-benzimidazol-2-yl]phenyl]cyclohexanecarboxamide;N-[4-(5,6-dichloro-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-(5,6-dimethyl-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-(6-fluoro-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]phenyl]cyclohexanecarboxamide has a molecular weight of 2274.01 g/mol, XLogP of 33.68, 20 rotatable bonds, 14 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for N-[4-(6-chloro-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-[6-(cyclohexylcarbamoylamino)-1H-benzimidazol-2-yl]phenyl]cyclohexanecarboxamide;N-[4-(5,6-dichloro-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-(5,6-dimethyl-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-(6-fluoro-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]phenyl]cyclohexanecarboxamide is sourced from PubChem (CID 161092745), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).